NDC 83301-0004-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0004
- Requested NDC
- 83301-0004-01
- Package NDCs from labels
- 83301-0004-1, 83301-0004-2, 83301-0004-3, 83301-0004-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0004-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 10 | |
| 83301-0004-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 10 | |
| 83301-0004-3 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0004 | GABAPENTIN CAPSULE [MULLAN PHARMACEUTICAL INC.] | 9 | Current NDC, 3 package rows | 20250411_74474aa4-4859-42d2-92d8-f23f18b34e04.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0004-1 | EA - Each | 83301-0004 | 68147702-10bf-45ab-8778-32f3f1b00f3e | 1 | 2024-10-04 |
| 83301-0004-2 | EA - Each | 83301-0004 | 8f01f50a-eb39-445e-a88a-4f1145bc24d1 | 1 | 2025-07-08 |
| 83301-0004-3 | EA - Each | 83301-0004 | 36e8797a-1182-42cb-aee7-d954f67ee1ce | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | 6ecf5114-2ddc-4025-a36d-1884702dc22a | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals Inc. | f396ec70-826d-45c6-a27c-343c2fac878c | 2026-04-29 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | 41dcc917-68d1-49f0-8223-44c21ca259ef | 2026-04-29 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Anything SPF | OCTINOXATE, OCTISALATE, ZINC OXIDE, AVOBENZONE, HOMOSALATE, TITANIUM DIOXIDE | Anything SPF LLC | 508b8dcb-6600-6dad-e063-6294a90a565a | 2026-04-28 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Coupler LLC | 5073abda-321f-29d1-e063-6394a90a59ac | 2026-04-27 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | BluePoint Laboratories | 3368bf70-d466-4765-b2b7-7fe967a8c2b7 | 2026-04-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 500ee820-0378-6fc9-e063-6394a90a109c | 2026-04-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Johnsons Baby Mineral Sunscreen SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 4fe04c4b-2751-0561-e063-6394a90af768 | 2026-04-22 | Warnings | 15FIX9V2JP |
| Lazy Face SPF 30 Facescreen | TITANIUM DIOXIDE, ZINC OXIDE | Sunny Day Creations | 500ee303-7302-68d5-e063-6394a90ac6d4 | 2026-04-22 | Warnings | 15FIX9V2JP |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | dd0e12c2-1986-4ca3-a809-d703a7542419 | 2026-04-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| ELROEL Pang Pang Sun Cushion S7 | ZINC OXIDE, TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | MONOGLOT HOLDINGS Inc. | 256bf56f-aefa-47ce-890c-5a3896c11b92 | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Fair | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | 3a43c7c0-7468-4b7a-95b9-f03e37f1b49b | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Fair Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | a251eb20-02e6-4b55-b969-c1bef2f9d732 | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Fair Pink | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | 6684d69a-89ff-41e8-81f0-3e2367811a18 | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | bf24d081-85f7-4a26-9416-ecff1fe59dec | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Pink Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | 4a09a01a-404f-4b67-91e0-666153f550e8 | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion N-Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | cf7c4445-0382-47ab-aba9-b40d63e4f1cc | 2026-04-17 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Cushion Medium | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | 80c60ffa-69e0-4b31-bd0d-fc8ff9936ba0 | 2026-04-17 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.